• Latest
  • Trending
Gilead fourth-quarter hepatitis C drug sales plummet; company sees a further slowdown

Gilead fourth-quarter hepatitis C drug sales plummet; company sees a further slowdown

February 8, 2018
4 dead, 52 arrested after Donald Trump supporters storm US Capitol

4 dead, 52 arrested after Donald Trump supporters storm US Capitol

January 7, 2021

China criticizes US order against dealing with Chinese apps

January 6, 2021

US has dual policy on Afghan peace process: MPs

January 5, 2021
‘Good riddance,’ says China snub Germany leaving UN Security Council

‘Good riddance,’ says China snub Germany leaving UN Security Council

December 25, 2020
Sharon Osbourne reveals she tested positive for COVID-19

Sharon Osbourne reveals she tested positive for COVID-19

December 15, 2020
Apple Adding Privacy Fact Labels to App Store Items

Apple Adding Privacy Fact Labels to App Store Items

December 15, 2020
More Republicans finally accept Biden win after U.S. Electoral College certifies vote

More Republicans finally accept Biden win after U.S. Electoral College certifies vote

December 15, 2020
Rhode Island casts 4 Electoral College votes for Biden

Rhode Island casts 4 Electoral College votes for Biden

December 15, 2020
Rhode Island School To Stagger Return After Holiday Break

Rhode Island School To Stagger Return After Holiday Break

December 15, 2020
Twitter, Facebook face labeling test on Trump’s election posts

Twitter, Facebook face labeling test on Trump’s election posts

November 4, 2020
Democratic hopes to flip US Senate dim as red wall holds for now

Democratic hopes to flip US Senate dim as red wall holds for now

November 4, 2020
US election: What happens next?

US election: What happens next?

November 4, 2020
Friday, April 23, 2021
No Result
View All Result
  • Region
    • Delaware
    • Maine
    • Massachusetts
    • New Hampshire
    • New Jersey
    • New York
    • Pennsylvania
    • Rhode Island
    • Vermont
  • U.S. News
  • National Security
    • Defense
    • Politics
    • Terrorism
  • World News
    • Africa
    • Asia
      • Australia & New Zealand
      • China
      • India
      • Japan
      • North & South Korea
    • Canada
    • Europe
      • Germany
      • Russian Federation
    • Latin America
      • Mexico
    • Middle East
    • United Kingdom
  • Economy
    • Business
    • Science
  • Sports
    • Auto Racing
    • Cycling
    • Golf
    • MLB
      • Boston Red Sox
      • New York Mets
    • NBA
      • Boston Celtics
      • Brooklyn Nets
    • NFL
      • New England Patriots
      • Philadelphia Eagles
      • New York Giants
      • New York Jets
    • NHL
      • Boston Bruins
      • Buffalo Sabres
      • New Jersey Devils
      • New York Islanders
      • New York Rangers
      • Philadelphia Flyers
      • Pittsburgh Penguins
    • Soccer
    • Tennis
    • Water Sports
  • Culture
    • Art
    • Books & Literature
    • Fashion
    • Health
    • History
    • Lifestyle & Family
    • Music
    • Religion
    • Television & Movies
    • Theatre
    • Travel
      • Great Outdoors
      • Rhode Island Travel
    • Women
  • Environment
    • Climate Change
    • Green News
    • Greenpeace
    • Oceans & Marinelife
    • Wildlife
  • Region
    • Delaware
    • Maine
    • Massachusetts
    • New Hampshire
    • New Jersey
    • New York
    • Pennsylvania
    • Rhode Island
    • Vermont
  • U.S. News
  • National Security
    • Defense
    • Politics
    • Terrorism
  • World News
    • Africa
    • Asia
      • Australia & New Zealand
      • China
      • India
      • Japan
      • North & South Korea
    • Canada
    • Europe
      • Germany
      • Russian Federation
    • Latin America
      • Mexico
    • Middle East
    • United Kingdom
  • Economy
    • Business
    • Science
  • Sports
    • Auto Racing
    • Cycling
    • Golf
    • MLB
      • Boston Red Sox
      • New York Mets
    • NBA
      • Boston Celtics
      • Brooklyn Nets
    • NFL
      • New England Patriots
      • Philadelphia Eagles
      • New York Giants
      • New York Jets
    • NHL
      • Boston Bruins
      • Buffalo Sabres
      • New Jersey Devils
      • New York Islanders
      • New York Rangers
      • Philadelphia Flyers
      • Pittsburgh Penguins
    • Soccer
    • Tennis
    • Water Sports
  • Culture
    • Art
    • Books & Literature
    • Fashion
    • Health
    • History
    • Lifestyle & Family
    • Music
    • Religion
    • Television & Movies
    • Theatre
    • Travel
      • Great Outdoors
      • Rhode Island Travel
    • Women
  • Environment
    • Climate Change
    • Green News
    • Greenpeace
    • Oceans & Marinelife
    • Wildlife
No Result
View All Result
No Result
View All Result

Gilead fourth-quarter hepatitis C drug sales plummet; company sees a further slowdown

February 8, 2018
in Culture, Health
0
Home Culture
Post Views: 223

 

Gilead Sciences on Tuesday said fourth-quarter sales of its flagship hepatitis C drugs fell by more than half amid increased competition, and the company forecast a further slowdown for the current year.

Gilead’s shares fell slightly after the closing bell.

For full-year 2018, the biotechnology company forecast product sales of $20 billion to $21 billion — including hepatitis C drug sales of $3.5 billion to $4 billion — down from $25.7 billion last year. Gilead projected a 2018 tax rate of 21 percent to 23 percent.

RelatedPosts

Gold eases as robust US retail sales trim rate cut hopes

US retail sales beat expectations in June

The Real Failure of Southeast Asia’s Drug Wars

Drug overdose deaths in R.I. declined in 2018, for second straight year

U.S. Gets Health Check as Recession Fears Persist

The company’s forecast implies 2018 earnings per share of $6.15, according to Mizuho Securities. Wall Street analysts, on average, expected 2018 earnings per share of $6.73, according to Thomson Reuters I/B/E/S.

Gilead, which last year paid nearly $12 billion for cancer immunotherapy company Kite Pharma, said it earned $1.78 a share in the fourth quarter excluding one-time items, which beat the average Wall Street estimate of $1.67 a share.

The quarterly results were “generally in line,” RBC Capital Markets analyst Brian Abrahams said in a research note. “Most notable news was Gilead’s 2018 guidance, where competitive dynamics (plus some market shrinkage) are expected to reduce HCV (hepatitis C virus) sales.”

Including a $6 billion charge related to U.S. corporate tax changes, Gilead posted a fourth-quarter net loss of $3.87 billion.

Quarterly sales of hepatitis C drugs totaled $1.5 billion, down from $3.2 billion a year earlier but in line with analysts’ forecasts. Sales of antiviral and HIV drug rose to $3.7 billion from $3.4 billion.

Shares of Gilead, which rose 2.5 percent to close at $80.38 in regular trading on the Nasdaq, were down 1 percent at $79.55 after-hours.

Source :
CNBC
Tags: CompanydrugGileadhepatitis CplummetSales
ShareTweetShare

Related Posts

Business

China criticizes US order against dealing with Chinese apps

January 6, 2021
Sharon Osbourne reveals she tested positive for COVID-19
Culture

Sharon Osbourne reveals she tested positive for COVID-19

December 15, 2020
Apple Adding Privacy Fact Labels to App Store Items
Business

Apple Adding Privacy Fact Labels to App Store Items

December 15, 2020
Rhode Island casts 4 Electoral College votes for Biden
Featured

Rhode Island casts 4 Electoral College votes for Biden

December 15, 2020
Best Accounting Software and Invoice Generators of 2020
Business

Best Accounting Software and Invoice Generators of 2020

October 27, 2020
Next Post
Two women say Marines did nothing after they complained of sexually explicit overtures by officer

Two women say Marines did nothing after they complained of sexually explicit overtures by officer

Translate

Popular Post

4 dead, 52 arrested after Donald Trump supporters storm US Capitol
Featured

4 dead, 52 arrested after Donald Trump supporters storm US Capitol

January 7, 2021
0

The chaotic and violent scene unfolded at the US Capitol as supporters of President Donald Trump swarmed the building to...

Read more
Mattis to Reassure Nervous Asian Allies

Mattis to Reassure Nervous Asian Allies

October 13, 2017
Asian Company Invest In America As Trump Takes Office

Asian Company Invest In America As Trump Takes Office

October 13, 2017
Trump lost: 9th Circuit Court declines restoring travel ban

Trump lost: 9th Circuit Court declines restoring travel ban

October 13, 2017
Central Intelligence: Gina Haspel new Deputy chief

Central Intelligence: Gina Haspel new Deputy chief

October 13, 2017
  • About Us
  • Creative Commons
  • Disclaimer
  • Privacy Policy
  • Terms & Conditions
  • Contact Us

Topics

Follow Us

About Us

Varnum Continental is part of Varnum Continental Media Group LLC, which daily news around the globe.

© 2011 Varnum Continental

No Result
View All Result
  • Region
    • Delaware
    • Maine
    • Massachusetts
    • New Hampshire
    • New Jersey
    • New York
    • Pennsylvania
    • Rhode Island
    • Vermont
  • U.S. News
  • National Security
    • Defense
    • Politics
    • Terrorism
  • World News
    • Africa
    • Asia
      • Australia & New Zealand
      • China
      • India
      • Japan
      • North & South Korea
    • Canada
    • Europe
      • Germany
      • Russian Federation
    • Latin America
      • Mexico
    • Middle East
    • United Kingdom
  • Economy
    • Business
    • Science
  • Sports
    • Auto Racing
    • Cycling
    • Golf
    • MLB
      • Boston Red Sox
      • New York Mets
    • NBA
      • Boston Celtics
      • Brooklyn Nets
    • NFL
      • New England Patriots
      • Philadelphia Eagles
      • New York Giants
      • New York Jets
    • NHL
      • Boston Bruins
      • Buffalo Sabres
      • New Jersey Devils
      • New York Islanders
      • New York Rangers
      • Philadelphia Flyers
      • Pittsburgh Penguins
    • Soccer
    • Tennis
    • Water Sports
  • Culture
    • Art
    • Books & Literature
    • Fashion
    • Health
    • History
    • Lifestyle & Family
    • Music
    • Religion
    • Television & Movies
    • Theatre
    • Travel
      • Great Outdoors
      • Rhode Island Travel
    • Women
  • Environment
    • Climate Change
    • Green News
    • Greenpeace
    • Oceans & Marinelife
    • Wildlife

© 2011 Varnum Continental